Flerie AB (publ) (FLERIE)
Market Closed
17 Jul, 15:25
XSTO 
kr
19. 95
-0.55
-2.6829%
kr
- Market Cap
- P/E Ratio
- Div Yield
17,565 Volume
- Eps
kr 20.5
Previous Close Want to track FLERIE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
FLERIE closed yesterday lower at kr19.95, a decrease of -2.6829% from Thursday's close, completing a monthly decrease of -25.8364% or -kr6.95. Over the past 12 months, FLERIE stock lost -46.729%.
FLERIE is not paying dividends to its shareholders.
The last earnings report, released on Apr 14, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -2.9219%, based on the last three reports.
Flerie AB (publ) has completed 2 stock splits, with the recent split occurring on May 15, 2026.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
FLERIE Chart
Flerie AB (publ) (FLERIE) FAQ
What is the stock price today?
The current price is kr19.95.
On which exchange is it traded?
Flerie AB (publ) is listed on XSTO.
What is its stock symbol?
The ticker symbol is FLERIE.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Flerie AB (publ) ever had a stock split?
Flerie AB (publ) had 2 splits and the recent split was on May 15, 2026.
Flerie AB (publ) Profile
| Biotechnology Industry | Healthcare Sector | Mr. Thomas Eldered M.Sc. CEO | XSTO Exchange | SE0022447348 ISIN |
| DE Country | 7 Employees | - Last Dividend | 15 May 2026 Last Split | - IPO Date |
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Contact Information
Address: Skeppsbron 16, Stockholm, Sweden, 111 30
Phone: 46 (0)76 131 01 27
Website: https://www.flerie.com
